College of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.
Department of Pharmacy, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830011, China.
J Asian Nat Prod Res. 2024 Mar;26(3):372-386. doi: 10.1080/10286020.2023.2221648. Epub 2023 Jun 13.
β-acetoxyisovalerylalkannin (β-AIVA) is one of shikonin/alkannin derivative, which were mainly extracted from Boraginaceae family. The effects of β-AIVA on human melanoma A375 cells and U918 cells were investigated . The CCK-8 assay showed that β-AIVA inhibited proliferation of cells. Results from flow cytometry, ROS assay and JC-1 assay showed that β-AIVA increased late apoptosis rate, induced the production of ROS and promoted mitochondrial depolarization in cells. β-AIVA regulated expressions of BAX and Bcl-2 proteins, and increased the expression of cleaved caspase-9 and cleaved caspase-3. These findings suggest that β-AIVA may be a potential therapeutic drug for treating melanoma.
β-乙酰氧基异戊酰紫草素(β-AIVA)是紫草素/紫草素衍生物之一,主要从紫草科中提取。研究了β-AIVA 对人黑色素瘤 A375 细胞和 U918 细胞的作用。CCK-8 检测表明β-AIVA 抑制细胞增殖。流式细胞术、ROS 检测和 JC-1 检测结果表明,β-AIVA 增加了晚期细胞凋亡率,诱导 ROS 产生,并促进线粒体去极化。β-AIVA 调节 BAX 和 Bcl-2 蛋白的表达,并增加了 cleaved caspase-9 和 cleaved caspase-3 的表达。这些发现表明,β-AIVA 可能是治疗黑色素瘤的潜在治疗药物。